Evaluation of the Efficacy of the Traditional Chinese Medicine Formulation Ru-Yi-Jin-Huang-Saan on Colles Fracture After Surgery: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial
JMIR Research Protocols · 2025
DOI: 10.2196/56849 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Lien-Cheng Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Chinese Medicine, China Medical University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Colles' Fracture, Medicine, Chinese Traditional. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Colles fracture, a common wrist injury, often requires surgical intervention. After surgery, patients may experience persistent pain and reduced wrist function, potentially resulting in long-term disability. In clinical practice, traditional Chinese medicine practitioners frequently use Ru-Yi-Jin-Huang-Saan (RYJHS) to treat such patients in Taiwan. RYJHS is a traditional Chinese herbal formula with a history spanning centuries, primarily used topically for the treatment of bone fractures and the promotion of healing. However, there is currently a lack of substantial clinical evidence supporting its efficacy in the management of postsurgical Colles fractures. To the best of our knowledge, there are no studies evaluating the clinical effectiveness of RYJHS.
Objective
This study aims to investigate the therapeutic potential of RYJHS in postsurgical Colles fracture cases. An additional objective is to provide an alternative treatment option for postoperative patients unable to take anti-inflammatory and pain relief medications.
Methods
This is a protocol for a randomized, double-blind, placebo-controlled trial. A total of 100 postoperative patients with Colles fracture, aged 20-80 years, will be recruited for this study. They will be randomly assigned to either the experimental or control group in a 1:1 allocation ratio. Both groups will receive standard postoperative Colles fracture treatment. The primary outcome measure will assess wrist functional recovery using the Patient-Rated Wrist Evaluation score. Secondary outcomes will include C-reactive protein levels and ultrasound measurements of wrist swelling. All of these examinations will be assessed at baseline, 3 days after surgery, and 6 days after surgery. In addition, the Dyshidrotic Eczema Area and Severity Index will be used to monitor for adverse skin reactions.
Results
This protocol was registered at ClinicalTrials.gov on December 6, 2022. It was performed in accordance with the approved guidelines and regulations of the participating institutions. Recruitment began in May 2023, with data collection expected to conclude in May 2025. Study completion is expected in December 2025.
Conclusions
This is the first protocol discussing the assessment of the therapeutic efficacy and safety of topical traditional Chinese medicine in patients after fracture surgery. The protocol will establish an integrated care model combining both traditional Chinese medicine and Western medicine for postsurgical fracture cases. Trial Registration ClinicalTrials.gov NCT05638360; https://clinicaltrials.gov/ct2/show/NCT05638360 International Registered Report Identifier (IRRID) DERR1-10.2196/56849
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Chinese Medicine, China Medical University, Taichung, Taiwan.
- Department of Traditional Chinese Medicine, Changhua Christian Hospital, Changhua, Taiwan.
- Department of Orthopedic Surgery, Changhua Christian Hospital, Changhua, Taiwan.
- Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
- School of Chinese Medicine, China Medical University, Taichung, Taiwan.
- Department of Chinese Medicine, China Medical University Hospital, Taichung, Taiwan.
ORCID-Profile: Lien-Cheng Lin, Wei-Hsun Wang, Wei-Kai Chang, Jyun-Liang Gao, Ru-Chang Yang, Po-Chi Hsu, Lun-Chien Lo
Zitieren
APA
Lin, L. C., Wang, W. H., Chang, W. K., Gao, J. L., Yang, R. C., Hsu, P. C., & Lo, L. C. (2025). Evaluation of the Efficacy of the Traditional Chinese Medicine Formulation Ru-Yi-Jin-Huang-Saan on Colles Fracture After Surgery: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/56849
Vancouver
Lin LC, Wang WH, Chang WK, Gao JL, Yang RC, Hsu PC, et al. Evaluation of the Efficacy of the Traditional Chinese Medicine Formulation Ru-Yi-Jin-Huang-Saan on Colles Fracture After Surgery: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/56849
BibTeX
@article{Lin2025,
author = {Lin, Lien-Cheng and Wang, Wei-Hsun and Chang, Wei-Kai and Gao, Jyun-Liang and Yang, Ru-Chang and Hsu, Po-Chi and Lo, Lun-Chien},
title = {Evaluation of the Efficacy of the Traditional Chinese Medicine Formulation Ru-Yi-Jin-Huang-Saan on Colles Fracture After Surgery: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/56849}
}
EUVIMED